在临床前的风湿性关节炎中,ExSMART-PreRA:可解释的生存和风险评估使用机器学习进行时间估计
IEEE journal of biomedical and health informatics
|March 26, 2025
概括
机器学习模型在临床前阶段预测了类风湿性关节炎 (RA) 发病风险. 风湿因子 (RF) 和抗CCP抗体水平的升高是早期RA发展的关键预测因素.
科学领域:
- 类风湿病学 类风湿病学
- 人工智能的人工智能
- 生物统计学 生物统计学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,影响周围关节.
- 临床前的RA涉及临床诊断前的抗体存在和不适,这对早期干预构成了挑战.
- 开发个体风险模型对于识别RA发病风险较高的个体至关重要.
研究的目的:
- 用生存机器学习模型估计RA发作的时间和风险.
- 为了确定预测RA发展的最佳模型.
- 将患者分为风险类别,并确定RA的关键风险因素.
主要方法:
- 分析了154名匿名的临床前RA患者的数据.
- 评估各种生存分析模型,包括随机生存森林和极端梯度增强生存.
- 使用夏普利添加式解释 (SHAP) 进行模型解释和风险因素识别.
主要成果:
- 随机生存森林模型表现出卓越的性能,平均C指数为0.798.
- 患者成功地被分为低,中,高风险的RA发病组.
- 类风湿因子 (RF) 和抗循环酸 (anti-CCP) 抗体的基线水平被确定为早期RA发作的显著预测因素.
结论:
- 生存机器学习模型可以有效预测在临床前阶段的RA发病风险.
- 识别关键风险因素,如RF和抗CCP抗体,可以提高个性化的患者管理.
- 这种方法为改善RA风险人群的临床实践和患者结果提供了有价值的见解.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
321
相关概念视频
Comparing the Survival Analysis of Two or More Groups
107
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
107
Introduction To Survival Analysis
144
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
144
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Assumptions of Survival Analysis
76
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
76
Kaplan-Meier Approach
67
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
67
